Neuropace Inc（NPCE）價格預測

$13.050

-0.444 (-3.40%)收盤時

價格預測

1-Day Price Prediction

+2.22%

1-Week Prediction

+1.83%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

NPCE 相似圖表分析預測

Alphio's NPCE stock price prediction model matches the current Neuropace Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.43 (+2.22%). The 1-week path is $13.38 (+1.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Neuropace Inc 股票嗎？

Neuropace Inc is not a strong buy right now due to its current price of $12.24, which is below the analyst price targets of $18 and $22. The RSI is at 32.355, indicating the stock is oversold, but the forward P/E ratio is extremely high at 158.73, suggesting overvaluation. The recent FDA denial for the RNS system expansion poses a significant risk, as it impacts the company's primary revenue source.

NPCE 股價於 Wednesday 收在 $13.05，此前下跌 -3.40%

Neuropace Inc (NPCE) last closed at $13.14, gaining +0.69%. These facts feed the 1-day and 1-week NPCE price prediction above.

預測驅動因素

Neuropace Inc（NPCE）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 NPCE 最接近的股票，依相似度排序。

CNQ

91.60%

+8.85%

90.85%

+1.43%

NTRA

90.69%

-5.99%

89.99%

-19.14%

CCC

89.70%

-34.00%

NPCE 季節性分析

Historically the probability of a positive October return for NPCE is 0.00%. December offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…